Germantown, MD, United States of America

Gregory E Agoston



 

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 26(Granted Patents)


Location History:

  • Germantown, MD (US) (2006 - 2012)
  • Rockville, MD (US) (2009 - 2012)

Company Filing History:


Years Active: 2006-2012

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Gregory E. Agoston

Introduction

Gregory E. Agoston is a notable inventor based in Germantown, MD (US), recognized for his significant contributions to the field of medical treatments. With a total of nine patents to his name, Agoston has focused on developing innovative methods for treating various disease states.

Latest Patents

Among his latest patents, Agoston has developed methods of treating disease states using antiangiogenic agents. This patent involves compositions and methods for treating mammalian diseases characterized by undesirable angiogenesis by administering an effective amount of specific compounds. Another significant patent is related to the method of treating disease states using substituted pyrazole compounds. This invention discloses protein kinase inhibitors and methods of treating diseases associated with protein kinases, particularly those related to cancer.

Career Highlights

Throughout his career, Agoston has worked with several prominent companies, including Entremed, Inc. and Miikana Therapeutics, Inc. His work has contributed to advancements in medical research and therapeutic applications.

Collaborations

Agoston has collaborated with notable professionals in his field, including Anthony Treston and Jamshed H. Shah. These collaborations have further enhanced his research and development efforts.

Conclusion

Gregory E. Agoston's innovative work and numerous patents reflect his dedication to improving medical treatments. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…